July 30, 2024

Enabling Clinical Trial Innovation Through AI Regulation at FDA

AI Featured, AI Regulation, Benefits of AI, Ethical AI, News

In this article:

As the FDA stakes its claim as the primary regulator of AI in healthcare, it must navigate the delicate balance between fostering innovation and ensuring safety and responsibility.
Innovation is a necessity in clinical trials – yet the US Clinical Trials system has a slow pace of innovation, which has impeded progress

Enabling Clinical Trial Innovation Through AI Regulation at FDA

RegulatingAI, a non-profit organization, is dedicated to establishing a platform for grassroots advocacy concerning artificial intelligence (AI) regulation. We serve as a bridge connecting AI experts, researchers, corporations, NGOs, academicians, students, and enthusiasts. RegulatingAI is committed to harnessing the power of shared knowledge to construct a responsible and ethical AI ecosystem.